Evidence map›Paper›PMID 35243873›Full record

ReviewJournal of the American Heart Association2022

Racial Disparities in Ion Channelopathies and Inherited Cardiovascular Diseases Associated With Sudden Cardiac Death.

Mohamed Chahine, John M Fontaine, Mohamed Boutjdir

Open access · goldAbstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Mohamed ChahineDepartment of Medicine Faculty of Medicine Université Laval Quebec City QC Canada.ORCID 0000-0002-9500-2839
John M FontaineUniversity of Pittsburgh Medical Center Williamsport PA.ORCID 0000-0003-2646-0956
Mohamed BoutjdirCardiovascular Research ProgramVeterans Administration New York Harbor Healthcare System New York NY.ORCID 0000-0002-6068-223X
State University of New York · USUniversité Laval · CAUniversity of Central Florida · US

Funding

Program to Increase Diversity in Cardiovascular Health-Related Research(PRIDE-CVD)R25HL105446 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI Mohamed Boutjdir · 2010 to 2026
$5.9M
NOVEL MECHANISMS AND THERAPEUTIC APPROACHES TO IMMUNO-INFLAMMATORY LONG OT SYNDROMEI01BX002137 · VA · VA NEW YORK HARBOR HLTHCARE/SYS/BROOKLYN · PI Mohamed Boutjdir · 2014 to 2026
–
BLRD VA I01 BX002137CIHR MOP‐111072CIHR MOP‐130373NHLBI NIH HHS R25 HL105446
6 · The paper itself

Abstract

Cardiovascular disease (CVD) continues to be the most common cause of death worldwide, and cardiac arrhythmias account for approximately one half of these deaths. The morbidity and mortality from CVD have been reduced significantly over the past few decades; however, disparities in racial or ethnic populations still exist. This review is based on available literature to date and focuses on known cardiac channelopathies and other inherited disorders associated with sudden cardiac death in African American/Black subjects and the role of epigenetics in phenotypic manifestations of CVD, and illustrates existing disparities in treatment and outcomes. The review also highlights the knowledge gaps that limit understanding of the manifestation of phenotypic abnormalities across racial or ethnic groups and discusses disparities associated with device underuse in the management of patients at risk for sudden cardiac death. We discuss factors related to reports in the United States, that the overall mortality attributed to CVD and the number of out-of-hospital cardiac arrests are higher among African American/Black subjects when compared with other racial or ethnic groups. African American/Black subjects are disproportionally affected by CVD, including cardiac arrhythmias and sudden cardiac death, thus highlighting a major concern in this population that remains underrepresented in clinical trials with limited genetic testing and device underuse. The proposed solutions include (1) early identification of genetic variants, which is crucial in tailoring a preventive management strategy; (2) inclusion of diverse racial or ethnic groups in clinical trials; (3) compliance with guideline-directed medical treatment and referral to cardiovascular subspecialists; and (4) training and mentoring of underrepresented junior faculty in cardiovascular health disparities research.

Indexed as

Cardiovascular DiseasesChannelopathiesDeath, Sudden, CardiacEthnicityHumansRacial GroupsUnited Statesethnicitygeneticsimplantable cardioverter‐defibrillatorion channelopathiesraceSCN5Asudden cardiac death

Identifiers

PMID35243873
PMCPMC9075281
OpenAlexW4214821659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.